5, 5-dimethyl-1-pyrroline-N-oxide (DMPO) was purchased from Alexis Biochemicals (Lausen, Switzerland).
Ciprofloxacin (CPFX),
norfloxacin (NRFX), pazfloxacin (PZFX),
levofloxacin (LVFX),
lomefloxacin (LFLX) and
1, 3-dimethylthiourea (DMTU) were purchased from Tokyo Chemical Industry Co., Ltd (Tokyo, Japan). Diethylenetriaminepentaacetic acid (DTPA), NaNO
2, NaNO
3 and
dextran were purchased from Nacalai Tesque (Kyoto, Japan).
Ficoll-Paque was purchased from GE Healthcare (Tokyo, Japan), and
phorbol 12-myristate 13-acetate (PMA) was purchased from Wako Pure Chemical Industries, Ltd (Osaka, Japan).
Mayer’s hematoxylin and eosin alcohol solutions were purchased from Muto Pure Chemicals (Tokyo, Japan).
Superoxide dismutase from bovine erythrocytes was purchased from Sigma (Tokyo, Japan).
Enoki Y., Ishima Y., Tanaka R., Sato K., Kimachi K., Shirai T., Watanabe H., Chuang V.T., Fujiwara Y., Takeya M., Otagiri M, & Maruyama T. (2015). Pleiotropic Effects of Levofloxacin, Fluoroquinolone Antibiotics, against Influenza Virus-Induced Lung Injury. PLoS ONE, 10(6), e0130248.